Majaz Moonis to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Majaz Moonis has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.843
-
Moonis M. High-dose statins should be used in all acute ischemic strokes. Stroke. 2012 Jul; 43(7):1992-3.
Score: 0.328
-
Moonis M, Kane K, Schwiderski U, Sandage BW, Fisher M. HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke. 2005 Jun; 36(6):1298-300.
Score: 0.202
-
Moonis M, Fisher M. HMG CoA reductase inhibitors (statins): use in stroke prevention and outcome after stroke. Expert Rev Neurother. 2004 Mar; 4(2):241-7.
Score: 0.186
-
Evans BA, Evans JE, Baker SP, Kane K, Swearer J, Hinerfeld D, Caselli R, Rogaeva E, St George-Hyslop P, Moonis M, Pollen DA. Long-term statin therapy and CSF cholesterol levels: implications for Alzheimer's disease. Dement Geriatr Cogn Disord. 2009; 27(6):519-24.
Score: 0.067
-
Hinerfeld DA, Moonis M, Swearer JM, Baker SP, Caselli RJ, Rogaeva E, St George-Hyslop P, Pollen DA. Statins differentially affect amyloid precursor protein metabolism in presymptomatic PS1 and non-PS1 subjects. Arch Neurol. 2007 Nov; 64(11):1672-3.
Score: 0.060